Jane
-
01:30:01 pm on December 19, 2007 | # |
The U.S. Food and Drug Administration (FDA) recently released its review of the safety events surrounding heart burn drugs Prilosec and Nexium to see whether these drugs increase the risks of heart attacks. Earlier in the year, the manufacturer of these drugs sent FDA long term study data looking at the treatment of severe gastroesophageal reflux disease (GERD) with Prilosec or Nexium.
An “Early Communication of an Ongoing Safety Review” of these drugs was released in August 2007 by the FDA, which found no increased risk of heart problems when using these drugs long-term. Additional safety information was submitted by the manufacturer and the FDA has conducted a comprehensive review of safety information relating to these drugs. Based on the FDA’s assessment it has concluded that long term use of Prilosec or Nexium is not likely to be linked to an increased risk of heart problems, and that health care providers can continue to prescribe these drugs to patients within the approved labeling. Source: FDA.